Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 6
Results: 36
Clara D. Bloomfield, M.D. (1942–2020): Legacy in Leukemia Research.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 543, doi. 10.1634/theoncologist.2020-0369
- By:
- Publication type:
- Article
I Have Cancer–Now What?
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 541, doi. 10.1634/theoncologist.2019-0820
- By:
- Publication type:
- Article
Taking the Longer View of COVID‐19.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 455, doi. 10.1634/theoncologist.2020-0313
- By:
- Publication type:
- Article
How to Guarantee the Best of Care to Patients with Cancer During the COVID‐19 Epidemic: The Italian Experience.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 463, doi. 10.1634/theoncologist.2020-0267
- By:
- Publication type:
- Article
Breaking Bad News via Telemedicine: A New Challenge at Times of an Epidemic.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e879, doi. 10.1634/theoncologist.2020-0284
- By:
- Publication type:
- Article
Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e993, doi. 10.1634/theoncologist.2020-0040
- By:
- Publication type:
- Article
NFE2L2/KEAP1 Mutations Correlate with Higher Tumor Mutational Burden Value/PD‐L1 Expression and Potentiate Improved Clinical Outcome with Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e955, doi. 10.1634/theoncologist.2019-0885
- By:
- Publication type:
- Article
The Finding of N‐Nitrosodimethylamine in Common Medicines.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 460, doi. 10.1634/theoncologist.2020-0142
- By:
- Publication type:
- Article
Nonresearch Pharmaceutical Industry Payments to Oncology Physician Editors.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e986, doi. 10.1634/theoncologist.2019-0828
- By:
- Publication type:
- Article
Exclusion of Men from Randomized Phase III Breast Cancer Clinical Trials.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e990, doi. 10.1634/theoncologist.2019-0871
- By:
- Publication type:
- Article
A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID‐19) Pandemic: An International Collaborative Group.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e936, doi. 10.1634/theoncologist.2020-0213
- By:
- Publication type:
- Article
Antitumor Activity of Larotrectinib in Esophageal Carcinoma with NTRK Gene Amplification.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e881, doi. 10.1634/theoncologist.2019-0641
- By:
- Publication type:
- Article
Cancer Research Ethics and COVID‐19.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 458, doi. 10.1634/theoncologist.2020-0221
- By:
- Publication type:
- Article
Clinical Characteristics of COVID‐19 After Gynecologic Oncology Surgery in Three Women: A Retrospective Review of Medical Records.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e982, doi. 10.1634/theoncologist.2020-0157
- By:
- Publication type:
- Article
Lack of Association Between Radiographic Tumor Burden and Efficacy of Immune Checkpoint Inhibitors in Advanced Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 515, doi. 10.1634/theoncologist.2019-0814
- By:
- Publication type:
- Article
Immunotherapy in Underrepresented Populations of Patients with Cancer: Do We Have Enough Evidence at Present? A Focus on Patients with Major Viral Infections and Autoimmune Disorders.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e946, doi. 10.1634/theoncologist.2020-0035
- By:
- Publication type:
- Article
A Multidisciplinary Team Approach to the Management of Patients with Hepatocellular Carcinoma with Portal Vein Tumor Thrombus.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e998, doi. 10.1634/theoncologist.2019-0196
- By:
- Publication type:
- Article
Hormone Receptor–Positive/Human Epidermal Growth Receptor 2–Negative Metastatic Breast Cancer in Young Women: Emerging Data in the Era of Molecularly Targeted Agents.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e900, doi. 10.1634/theoncologist.2019-0729
- By:
- Publication type:
- Article
The Safety and Efficacy of Checkpoint Inhibitors in Transplant Recipients: A Case Series and Systematic Review of Literature.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 505, doi. 10.1634/theoncologist.2019-0659
- By:
- Publication type:
- Article
Efficacy of Cabozantinib and Nivolumab in Treating Hepatocellular Carcinoma with RET Amplification, High Tumor Mutational Burden, and PD‐L1 Expression.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 470, doi. 10.1634/theoncologist.2019-0563
- By:
- Publication type:
- Article
Regarding Acupuncture for Chemotherapy‐Induced Peripheral Neuropathy.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e999, doi. 10.1634/theoncologist.2019-0819
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e1000, doi. 10.1634/theoncologist.2019-0933
- By:
- Publication type:
- Article
Pilot Study of Hyperfractionated Dosing of Lutetium‐177–Labeled Antiprostate‐Specific Membrane Antigen Monoclonal Antibody J591 (<sup>177</sup>Lu‐J591) for Metastatic Castration‐Resistant Prostate Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 477, doi. 10.1634/theoncologist.2020-0028
- By:
- Publication type:
- Article
EMA Recommendation for the Pediatric Indications of Plerixafor (Mozobil) to Enhance Mobilization of Hematopoietic Stem Cells for Collection and Subsequent Autologous Transplantation in Children with Lymphoma or Malignant Solid Tumors.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e976, doi. 10.1634/theoncologist.2019-0898
- By:
- Publication type:
- Article
Prognostic Value of HER2 to CEP17 Ratio on Fluorescence In Situ Hybridization Ratio in Patients with Nonmetastatic HER2‐Positive Inflammatory and Noninflammatory Breast Cancer Treated with Neoadjuvant Chemotherapy with or without Trastuzumab.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e909, doi. 10.1634/theoncologist.2018-0611
- By:
- Publication type:
- Article
Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 481, doi. 10.1634/theoncologist.2019-0611
- By:
- Publication type:
- Article
Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e928, doi. 10.1634/theoncologist.2019-0736
- By:
- Publication type:
- Article
Early Phase Pediatric Cancer Trials: Progress Highlights Challenges.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 468, doi. 10.1634/theoncologist.2019-0942
- By:
- Publication type:
- Article
A Systematic Review of Pediatric Phase I Trials in Oncology: Toxicity and Outcomes in the Era of Targeted Therapies.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 532, doi. 10.1634/theoncologist.2019-0615
- By:
- Publication type:
- Article
A Randomized Trial of Real‐Time Geriatric Assessment Reporting in Nonelectively Hospitalized Older Adults with Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 488, doi. 10.1634/theoncologist.2019-0581
- By:
- Publication type:
- Article
Inverse Association of Age with Risk of Lymph Node Metastasis in Superficial Colorectal Cancer: A Large Population‐Based Study.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e920, doi. 10.1634/theoncologist.2019-0815
- By:
- Publication type:
- Article
Understanding the Financial Needs Following Diagnosis of Breast Cancer in a Setting with Universal Health Coverage.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 497, doi. 10.1634/theoncologist.2019-0426
- By:
- Publication type:
- Article
Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. e964, doi. 10.1634/theoncologist.2019-0661
- By:
- Publication type:
- Article
A Phase II Study of Pazopanib in Patients with Malignant Pleural Mesothelioma: NCCTG N0623 (Alliance).
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 523, doi. 10.1634/theoncologist.2019-0574
- By:
- Publication type:
- Article
Updated Survival Data for a Phase I/II Study of Carboplatin plus Nab‐Paclitaxel and Concurrent Radiotherapy in Patients with Locally Advanced Non‐Small Cell Lung Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 475, doi. 10.1634/theoncologist.2019-0746
- By:
- Publication type:
- Article
A Phase I Trial Using a Multitargeted Recombinant Adenovirus 5 (CEA/MUC1/Brachyury)‐Based Immunotherapy Vaccine Regimen in Patients with Advanced Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 6, p. 479, doi. 10.1634/theoncologist.2019-0608
- By:
- Publication type:
- Article